Journal of Hepatology
Volume 51, Issue 1 , Pages 4-7, July 2009

What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: Viral dynamics, viral levels at certain time points, or a combination of both?

  • Ola Weiland

      Affiliations

    • Corresponding Author InformationTel.: +46 8 58580000; fax: +46 8 58581916.

Department of Medicine, Division of Infectious Diseases, 173 Karolinska University Hospital Huddinge at Karolinska Institutet, 14186 Stockholm, Sweden

published online 17 April 2009.

Associate Editor: M. Colombo

Abbreviations: HCV, hepatitis C virus, PEG-IFN, pegylated interferon, RBV, ribavirin, CHC, chronic hepatitis C, SVR, sustained virologic response, NPV, negative predictive value, PPV, high positive predictive value, VD, viral decline, VL, viral load

No abstract is available. To read the body of this article, please view the Full Text online.

 

 The author has declared that he has received grants from Schering-Plough, Roche, Tibotec and Swedish Orphans and has declared that that he has been on the Speakers Bureau for Schering-Plough, Roche, Tibotec, Swedish Orphans, Bristol Myers Squibb, Gilead and Novartis. He also declared that he is the P.I. in Sweden for studies run by Roche, Schering-Plough, Merch Sharp; Dome Limited and Swedish Orphans.

PII: S0168-8278(09)00240-2

doi:10.1016/j.jhep.2009.04.002

Refers to article:

  • Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C , 12 March 2009

    Avidan U. Neumann, Stephen Pianko, Stefan Zeuzem, Eric M. Yoshida, Yves Benhamou, Moshe Mishan, John G. McHutchison, Erik Pulkstenis, G. Mani Subramanian
    Journal of Hepatology July 2009 (Vol. 51, Issue 1, Pages 21-28)

Journal of Hepatology
Volume 51, Issue 1 , Pages 4-7, July 2009